B

BMC Medical Co Ltd
SZSE:301367

Watchlist Manager
BMC Medical Co Ltd
SZSE:301367
Watchlist
Price: 68.07 CNY -3.86% Market Closed
Market Cap: 6.1B CNY
Have any thoughts about
BMC Medical Co Ltd?
Write Note

BMC Medical Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BMC Medical Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
B
BMC Medical Co Ltd
SZSE:301367
Other Long-Term Assets
ÂĄ18.7m
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Other Long-Term Assets
ÂĄ61.5m
CAGR 3-Years
67%
CAGR 5-Years
116%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Other Long-Term Assets
ÂĄ263.2m
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
31%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Other Long-Term Assets
ÂĄ2.1B
CAGR 3-Years
64%
CAGR 5-Years
30%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Other Long-Term Assets
ÂĄ122.6m
CAGR 3-Years
32%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Other Long-Term Assets
ÂĄ541.5m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BMC Medical Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Health Care

BMC Medical Co. Ltd. principally engages in the research, development, production, and sale of medical equipment and consumable products in the field of respiratory health. The company is headquartered in Beijing, Beijing and currently employs 843 full-time employees. The company went IPO on 2022-11-01. The firm's products mainly include non-invasive home ventilators, ventilation masks, sleep monitors and high-flow humidified oxygen therapy devices. The firm also provides respiratory health chronic disease management services. The firm focuses on the treatment of patients with sleep apnea-hypopnea syndrome (SAHS), mainly obstructive sleep apnea syndrome (OSA), as well as patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD), providing a full-cycle and multi-scenario overall solution for treatment services.

Intrinsic Value
63.17 CNY
Overvaluation 7%
Intrinsic Value
Price
B

See Also

What is BMC Medical Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
18.7m CNY

Based on the financial report for Dec 31, 2023, BMC Medical Co Ltd's Other Long-Term Assets amounts to 18.7m CNY.

What is BMC Medical Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
29%

Over the last year, the Other Long-Term Assets growth was 3%. The average annual Other Long-Term Assets growth rates for BMC Medical Co Ltd have been 29% over the past three years .

Back to Top